Title In Vivo Persistence of Human Rhinoviruses in Immunosuppressed Patients.
Author Engelmann, Ilka; Dewilde, Anny; Lazrek, Mouna; Batteux, Mathilde; Hamissi, Aminati; Yakoub-Agha, Ibrahim; Hober, Didier
Journal PLoS One Publication Year/Month 2017
PMID 28151988 PMCID PMC5289482
Affiliation + expend 1.Laboratoire de Virologie EA 3610, Faculte de Medecine, Universite Lille et CHU Lille, Lille, France.

Several species of the genus Enterovirus cause persistent infections in humans. Human rhinovirus (HRV) infections are generally self-limiting but occasionally persistent infections have been described. This study aimed to identify persistent HRV infections and investigate the clinical and virologic characteristics of patients with persistent infections. From January 2012 to March 2015, 3714 respiratory specimens from 2608 patients were tested for respiratory viruses by using a multiplex reverse transcription-polymerase chain reaction. A retrospective study was performed. Patients with at least two specimens positive for HRV/enterovirus taken 45 days or longer apart were identified and the HRV/enteroviruses were typed. Patients with persistent infection were compared to patients with reinfection and patients with cleared infection. Phylogenetic analysis of the viral protein(VP)4/VP2 region was performed. 18 patients with persistent HRV/enterovirus infection were identified. Minimum median duration of persistence was 92 days (range 50-455 days). All but one patients with persistence were immunosuppressed. Immunosuppression and hematologic disorders were more frequent in patients with persistence (n = 18) than in patients with reinfection (n = 33) and with cleared infection (n = 25) (p = 0.003 and p = 0.001, respectively). In conclusion, this retrospective study identified HRV persistence in vivo which occurred mainly in immunosuppressed patients.

StrainID RV Species Serotype Length(nt) Country Year Strain Name
CNM03475 C None 389 France 2014 50B
CNM03480 C None 389 France 2014 47B
CNM03485 C None 389 France 2014 39C
CNM03490 C None 389 France 2014 29B
CNM03495 C None 389 France 2013 23A
CNM03500 C None 389 France 2012 10A
CNP03472 C None 389 France 2014 59B
CNP03477 C None 389 France 2014 48C
CNP03482 C None 389 France 2014 41B
CNP03487 C None 389 France 2014 33C
CNP03492 C None 389 France 2013 26A
CNP03497 C None 389 France 2013 22A
CNS03473 C None 389 France 2015 58B
CNS03478 C None 389 France 2014 48A
CNS03483 C None 389 France 2014 40B
CNS03488 C None 389 France 2014 33A
CNS03493 C None 389 France 2013 25A
CNS03498 C None 389 France 2013 14B
CNZ03471 C None 387 France 2013 7D
CNZ03476 C None 256 France 2014 50A
CNZ03481 C None 389 France 2013 47A
CNZ03486 C None 389 France 2014 39A
CNZ03491 C None 389 France 2012 29A
CNZ03496 C None 389 France 2013 22B
  • Copyright © 2023
    National Institute of Pathogen Biology, CAMS & PUMC, Bejing, China
    All rights reserved.